Related Experiment Videos
[Cardiorespiratory problems in the use of calcium antagonists for vasospasm prophylaxis in subarachnoid hemorrhage]
Insights
Calcium antagonists like nimodipine, used for subarachnoid hemorrhage (SAH), can increase intrapulmonary shunting. This may dangerously reduce oxygen supply in SAH patients with existing cerebral hypoxia.
Area of Science:
- Cardiovascular Physiology
- Neurocritical Care
Context:
- Calcium antagonists are standard for preventing cerebral vasospasm post-acute subarachnoid hemorrhage (SAH).
- Known cardiovascular effects include vasodilation, hypotension, and altered cardiac output.
- Intrapulmonary shunting (Qs/Qt) is a recognized but less emphasized cardiovascular effect.
Purpose:
- To investigate the correlation between nimodipine administration and intrapulmonary shunting in a patient with SAH.
- To discuss the clinical implications of nimodipine-induced intrapulmonary shunting in SAH patients.
Summary:
- A case study of a 34-year-old woman treated with nimodipine after SAH is presented.
- Invasive hemodynamic monitoring (Swan-Ganz-thermodilution catheter) revealed a correlation between nimodipine and increased intrapulmonary shunting.
- This finding highlights a potential hazard in SAH management.
Impact:
- Increased intrapulmonary shunting can exacerbate hypoxia in SAH patients.
- SAH patients are uniquely vulnerable to decreased oxygen supply due to pre-existing cerebral ischemic hypoxia.
- This underscores the need for careful hemodynamic monitoring during calcium antagonist therapy in SAH.
Abstract:
Since studies by Allen et al. [1] calcium antagonists have been commonly used for prevention of cerebral vasospasm in patients suffering from acute subarachnoid hemorrhage (SAH). Vasodilatation-induced hypotension, increase of cardiac output and intrapulmonary shunting (Qs/Qt) are wellknown cardiovascular effects. These problems are discussed in light of previous reports and present case study of a 34-year-old woman treated with the calcium antagonist nimodipine after SAH. Reproducible results from invasive haemodynamic monitoring (Swan-Ganz-thermodilution catheter) indicated correlation between nimodipine application and increased intrapulmonary shunting. This effect can be hazardous for SAH patients because preexisting cerebral ischemic hypoxia makes them particularly susceptible to additional decrease in oxygen supply.